Venture Visionary Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $223K | Buy |
2,685
+50
| +2% | +$4.15K | 0.01% | 530 |
|
2025
Q1 | $214K | Sell |
2,635
-10
| -0.4% | -$811 | 0.01% | 516 |
|
2024
Q4 | $238K | Sell |
2,645
-271
| -9% | -$24.4K | 0.01% | 491 |
|
2024
Q3 | $288K | Buy |
2,916
+1
| +0% | +$99 | 0.01% | 463 |
|
2024
Q2 | $270K | Sell |
2,915
-2,425
| -45% | -$225K | 0.01% | 469 |
|
2024
Q1 | $507K | Buy |
+5,340
| New | +$507K | 0.02% | 371 |
|
2022
Q3 | – | Sell |
-1,308
| Closed | -$97.1K | – | 1567 |
|
2022
Q2 | $97.1K | Buy |
+1,308
| New | +$97.1K | 0.01% | 614 |
|
2021
Q4 | – | Sell |
-8,475
| Closed | -$1.07M | – | 538 |
|
2021
Q3 | $1.07M | Buy |
+8,475
| New | +$1.07M | 0.08% | 211 |
|